Ajax-Loading

Roche Holding AG - Current Deferred Revenue

Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.

The item "Current-Deferred-Revenue" stands at 2.60 Billion Swiss Francs as of 06/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.98 Billion Swiss Francs compared to the value the year prior.
The 1 year change is -0.98 Billion Swiss Francs.
The 3 year change is -0.877 Billion Swiss Francs.
The 5 year change is 6.77 Billion Swiss Francs.
The 10 year change is 6.98 Billion Swiss Francs.

The Serie's long term average value is -0.153 Billion Swiss Francs. It's latest available value, on 06/30/2024, is 2.75 Billion Swiss Francs higher, compared to it's long term average value.
The Serie's change in Swiss Francs from it's minimum value, on 06/30/2016, to it's latest available value, on 06/30/2024, is +11.00 Billion.
The Serie's change in Swiss Francs from it's maximum value, on 12/31/2012, to it's latest available value, on 06/30/2024, is -9.75 Billion.

Current Deferred Revenue for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Current Deferred Revenue905,699,262,464.00
LogoJohnson & Johnson - Current Deferred Revenue486,508,953,600.00
LogoAbbVie Inc - Current Deferred Revenue399,570,305,024.00
LogoAstraZeneca PLC - Current Deferred Revenue280,205,508,085.11
LogoNovartis AG - Current Deferred Revenue255,096,620,580.91